<h1>Vijaya Diagnostic Centre Limited Allots 100,987 Equity Shares Under ESOP Plan</h1>
Vijaya Diagnostic Centre Limited has announced a significant increase in its issued share capital following the allotment of equity shares to employees who exercised options under the VDCL Employee Stock Option Plan 2018. The allotment was approved by the Nomination and Remuneration Committee of the company's Board of Directors.
The issuance of 100,987 equity shares, each having a face value of ₹1/-, led to an increase in the issued, subscribed, and paid-up equity share capital of the Company. Prior to this allotment, the capital stood at ₹10,28,96,728/-. Following the successful allotment, the total paid-up capital increased to ₹10,29,97,715/-.
The shares allotted are designated as equity shares under the Vijaya Diagnostic Centre Limited Employee Stock Option Plan 2018.
Share Issuance Details
The following table provides details regarding the allotment of equity shares:| Particulars | Detail |
|---|---|
| Shares Allotted in this Issue | 100,987 |
| Face Value per Share | ₹1/- |
| Total Issued Shares After This Issue | 10,29,97,715 |
| Equity Plan Reference | VDCL Employee Stock Option Plan 2018 |
Exercise Price and Premium Breakdown
The allotment covered shares exercised at various prices, reflecting different terms under the stock option plan. Specific details of the exercise price and premium per share are as follows:| Share Group Size | Exercise Price per Share | Premium per Share |
|---|---|---|
| 53,339 shares | ₹318.00/- | ₹317.00/- |
| 28,948 shares | ₹519.00/- | ₹518.00/- |
| 18,700 shares | ₹815.00/- | ₹814.00/- |
The allotted equity shares are identical in all respects to the Company's existing equity shares. Furthermore, no lock-in period has been imposed on these newly allotted shares.
VIJAYA Stock Price Movement
Shares of Vijaya Diagnostic Centre Limited slipped on Wednesday, closing at ₹1313.1 after shedding 1.60%. The stock saw significant trading volume of 165,232 shares during the session.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.